Brivudine-13C, 15N2
Brivudine-13C, 15N2 (Bromovinyldeoxyuridine-13C, 15N2) is 13C and 15N labeled Brivudine. Brivudine is a thymidine analogue with antiviral activity, indicated for the early treatment of acute herpes zoster.
Product Specifications
Product Name Alternative
Bromovinyldeoxyuridine-13C, 15N2; BVDU-13C, 15N2
UNSPSC
12352005
Target
CMV; Isotope-Labeled Compounds
Related Pathways
Anti-infection; Others
Applications
COVID-19-anti-virus
Field of Research
Infection; Cancer
Smiles
O=[13C]1[15N](C=C(C([15NH]1)=O)/C=C/Br)[C@@H]2O[C@@H]([C@H](C2)O)CO
Molecular Formula
C10 13CH13Br 15N2O5
Molecular Weight
336.11
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Rabasseda X, et al. Brivudine: a herpes virostatic with rapid antiviral activity and once-daily dosing. Drugs Today (Barc) . 2003 May;39 (5) :359-71.|[3]Keam SJ, et al. Brivudin (bromovinyl deoxyuridine) . Drugs. 2004;64 (18) :2091-7; discussion 2098-9.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470270-100 1x 100 µL
Fibronectin (HFN7.1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742853-500 1x 500 µL
CD54 / ICAM-1 (15.2), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401073-100 1x 100 µL
HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details